Target intelligence / Profile preview

Tetanus neurotoxin heavy chain N-terminal fragment (TeNT-Hn)

Target
TeNT-Hn
Molecular classification
Bacterial toxin, Translocation protein
01

Overview

Tetanus neurotoxin (TeNT) is a highly potent protein toxin produced by the bacterium Clostridium tetani, responsible for the life-threatening condition known as tetanus, which is characterized by spastic paralysis (StatPearls, 2023). The heavy-chain N-terminal fragment, often designated as the Hn domain, serves as the translocation machinery of the toxin (UniProt P04958). Following the binding of the C-terminal fragment to neuronal receptors and subsequent endocytosis, the Hn domain undergoes a pH-dependent conformational change within the acidic environment of the endosome (Pirazzini et al., 2017). This change allows the Hn fragment to insert into the endosomal membrane and form a channel through which the catalytic light chain is delivered into the cytosol. Once inside, the light chain cleaves vesicle-associated membrane protein 2 (VAMP2), preventing the release of inhibitory neurotransmitters (PubMed, PMC5033269). The Hn fragment is a critical target for neutralizing antibodies found in tetanus immune globulin and those elicited by the tetanus toxoid vaccine (Rossetto et al., 2014).

Other names
Hn domainTranslocation domain of tetanus toxinTetanus toxin heavy chain N-terminal fragment
02

Mechanism of action

Neutralization of toxin translocation into the neuronal cytosol by binding to the Hn domain.

03

Biological functions

Membrane translocationProtein transportPore formation
04

Disease associations

TetanusInfection
05

Safety considerations

Extreme potency of the holotoxinRisk of neuromuscular blockadeImmunogenicity
06

Interacting drugs

Tetanus immune globulin

1 more in the full profile.

07

Biomarkers

Anti-tetanus antibody titer

Beyond the preview

Go deeper on Tetanus neurotoxin heavy chain N-terminal fragment (TeNT-Hn).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetanus neurotoxin heavy chain N-terminal fragment (TeNT-Hn).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call